title: Impact of standardization of antimicrobial prophylaxis duration in pediatric cardiac surgery.
abstract: The optimal duration of antimicrobial prophylaxis following pediatric cardiac surgery is still debated. Adult studies suggest that shorter durations are adequate, but there is a paucity of data on pediatric patients.
  
  
  
  This quasi-experimental study reviewed the charts of patients 18 years and younger who underwent cardiac surgery from April 2011 to November 2014 at a single institution. Starting in April 2013, a protocol was implemented to limit antimicrobial prophylaxis to 48 hours following sternal closure. Two analyses were performed: (1) identification of risk factors for surgical site infections from the entire cohort, and (2) comparison of surgical site infection incidence in the pre- and postprotocol groups.
  
  
  
  In the entire cohort, delayed sternal closure (adjusted odds ratio [OR], 5.7; 95% confidence interval [CI], 1.8-17.9) and younger age (adjusted OR, 2.1; 95% CI, 1.1-3.8) were associated with incidence of surgical site infection. Following the protocol change, duration of antimicrobial prophylaxis decreased from 4.2 ± 2.7 to 1.9 ± 1.3 days (P < .0001). After adjusting for age and delayed sternal closure, the postprotocol group had an adjusted OR of 0.98 (95% CI, 0.32-3.00) for occurrence of surgical site infection. Other outcomes were not altered following the protocol change.
  
  
  
  Restricting antimicrobial prophylaxis to 48 hours following pediatric cardiac surgery did not increase the incidence of surgical site infection at our institution. Further study is needed to validate this finding and to identify practices that reduce surgical site infections in those with delayed sternal closure.
authors.affiliation: Pacific University, School of Pharmacy, Hillsboro, Ore; Randall Children's Hospital at Legacy Emanuel, Portland, Ore.
authors.forename: Sundeep
authors.initials: S
authors.lastname: Bath
authors.affiliation: Randall Children's Hospital at Legacy Emanuel, Portland, Ore.
authors.forename: Jason
authors.initials: J
authors.lastname: Lines
authors.affiliation: Randall Children's Hospital at Legacy Emanuel, Portland, Ore.
authors.forename: Ann M
authors.initials: AM
authors.lastname: Loeffler
authors.affiliation: Pacific University, School of Pharmacy, Hillsboro, Ore.
authors.forename: Ashim
authors.initials: A
authors.lastname: Malhotra
authors.affiliation: Pacific University, School of Pharmacy, Hillsboro, Ore; Randall Children's Hospital at Legacy Emanuel, Portland, Ore. Electronic address: brigg.turner@pacificu.edu.
authors.forename: R Brigg
authors.initials: RB
authors.lastname: Turner
mesh_terms: D000293:Adolescent; D019072:Antibiotic Prophylaxis / Q000592:standards*; D006348:Cardiac Surgical Procedures; D002648:Child; D002675:Child, Preschool; D005260:Female; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D012307:Risk Factors; D056346:Sternotomy; D013530:Surgical Wound Infection / Q000517:prevention & control*
keywords: antibiotics; antifungals; antiviral agents; infection; wound infection